康妇消炎栓与盆腔炎治疗仪联合治疗盆腔炎所致慢性疼痛疗效分析

Analysis of curative effect of Kangfu anti-inflammatory suppository combined with pelvic inflammatory Thera Therapeutic apparatus on chronic pain caused by pelvic inflammatory Disease

目的:探讨盆腔炎所致慢性疼痛应用康妇消炎栓联合盆腔炎治疗疾病的效果。方法:选取2017年2月~2018年2月本院接收的盆腔炎所致慢性疼痛患者86例,随机分成观察组与对照组各43例。对照组使用康妇消炎栓治疗,观察组则采用康妇消炎栓联合盆腔炎治疗仪治疗,观察两组患者治疗效果。结果:观察组疼痛缓解时间明显短于对照组(P<0.05),治疗后两组患者VAS评分均下降,且观察组VAS评分显著低于对照组(P<0.05)。观察组下腹坠痛、盆腔积液、附件包块、白带增多出现率显著低于对照组(P<0.05)。观察组不良反应发生率显著低于对照组(P<0.05)。结论:采取康妇消炎栓联合盆腔炎治疗仪治疗盆腔炎所致慢性疼痛可以缓解患者疼痛,改善患者的临床症状,降低患者不良反应发生率,值得推广。

Objective： Effect of Kangfu anti-inflammatory suppository combined with pelvic inflammatory Disease on chronic pain caused by pelvic inflammatory Disease. Methods： From February 2017 to February 2018, 86 patients with chronic pain caused by pelvic inflammatory disease were randomly divided into two groups： observation group（n = 43） and control group（n = 43）.The control group was treated with Kangfu anti-inflammatory suppository, and the observation group was treated with Kangfu anti-inflammatory suppository combined with pelvic inflammatory therapy instrument. Results： The pain relief time of the observation group was significantly shorter than that of the control group（P〈0.05）. After treatment, the VAS score of the two groups decreased, and the VAS score of the observation group was significantly lower than that of the control group（P〈0.05）.The incidence of lower abdominal pain, pelvic effusion, adnexal mass and leucorrhea in the observation group was significantly lower than that in the control group（P〈0.05）. The incidence of adverse reactions in the observation group was significantly lower than that in the control group（P〈0.05）.Conclusion： The treatment of chronic pain caused by pelvic inflammatory disease with Kangfu anti-inflammatory suppository combined with pelvic inflammatory device can relieve pain, improve clinical symptoms of patients, and reduce the incidence of adverse reactions. It is worthy of promotion.